As of 4:00pm ET
| -0.17 / -5.04%|
The 5 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 6.00, with a high estimate of 9.00 and a low estimate of 0.20. The median estimate represents a +87.50% increase from the last price of 3.20.
The current consensus among 6 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.